Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ThermoDox + Hyperthermia in Recurrent Breast Cancer
NCT00826085Phase 2Completed
- Sponsor
- Imunon, Inc.
- Start
- Feb 2013
- Primary completion
- Dec 2015
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ThermoDox in breast cancer, sponsored by Imunon, Inc.. Started Feb 2013; status: completed.
02
Drugs
ThermoDox
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00826085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00826085.